Drugs / HZ/su
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02114333 Comparator | May 2014 → Mar 2016 | herpes zoster | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HZ/su | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02114333 ↗ |
| Modality | Vaccine | “One vaccine is live (Zostavax, licensed by FDA) and the other, herpes zoster subunit (HZ/su), contains a piece of the shingles virus (not live) and an ingredient that may...” NCT02114333 ↗ |
| Route | Intramuscular | “First dose recombinant vaccine, HZ/su (0.5ml, intramuscular)” NCT02114333 ↗ |